Beyondspring Inc (BYSI) Stock: What Does the Chart Say Thursday?

Overall market sentiment has been neutral on Beyondspring Inc (BYSI) stock lately. BYSI receives a Neutral rating from InvestorsObserver Stock Sentiment Indicator.

Beyondspring Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on BYSI!

See Full BYSI Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With BYSI Stock Today?

Beyondspring Inc (BYSI) stock is higher by 1.39% while the S&P 500 is down -0.36% as of 10:44 AM on Thursday, Jun 9. BYSI has risen $0.03 from the previous closing price of $2.16 on volume of 194,085 shares. Over the past year the S&P 500 is down -2.99% while BYSI is down -81.12%. BYSI lost -$1.64 per share in the over the last 12 months.

More About Beyondspring Inc

BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China. Click Here to get the full Stock Report for Beyondspring Inc stock.